These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3848413)

  • 1. Fulminant hepatic failure and artificial liver support.
    Williams R; Ede R; Gimson AE; Hughes RD
    Indian J Gastroenterol; 1985 Jul; 4(3):177-80. PubMed ID: 3848413
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemoperfusion through activated charcoal in dogs with fulminant liver failure.
    Horák J; Horký J; Rábl M
    Digestion; 1980; 20(1):22-30. PubMed ID: 7353731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.
    Kodali S; McGuire BM
    Clin Liver Dis; 2015 Aug; 19(3):565-76. PubMed ID: 26195209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
    Dixit V; Chang TM
    Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
    Chirito E; Reiter B; Lister C; Chang TM
    Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats.
    Tabata Y; Chang TM
    Trans Am Soc Artif Intern Organs; 1980; 26():394-9. PubMed ID: 7245521
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver support systems: the low clearance of model hepatic excretory anions by charcoal hemoperfusion.
    Hew JT; Hart FE; Willson RA
    Gastroenterology; 1978 Apr; 74(4):661-3. PubMed ID: 631502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with fulminant hepatic failure and brain edema.
    Toftengi F; Larsen FS
    Metab Brain Dis; 2004 Dec; 19(3-4):207-14. PubMed ID: 15554416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic encephalopathy and cerebral edema.
    Ede RJ; Williams RW
    Semin Liver Dis; 1986 May; 6(2):107-18. PubMed ID: 3018935
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral oedema and monitoring of intracranial pressure in fulminant hepatic failure.
    Ede R; Gimson AE; Cannalese J; Williams R
    Gastroenterol Jpn; 1982 Apr; 17(2):163-76. PubMed ID: 6809520
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure.
    Rozga J; Podesta L; LePage E; Hoffman A; Morsiani E; Sher L; Woolf GM; Makowka L; Demetriou AA
    Lancet; 1993 Oct; 342(8876):898-9. PubMed ID: 8105168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of charcoal hemoperfusion with prostacyclin on the coagulation-fibrinolysis system and platelets of patients with fulminant hepatic failure--preliminary observations.
    Cordopatri F; Boncinelli S; Marsili M; Lorenzi P; Fabbri LP; Paci P; Salvadori M; Morfini M; Cinotti S; Casparini P
    Int J Artif Organs; 1982 Jul; 5(4):243-7. PubMed ID: 6749697
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver support in acute liver failure.
    Hughes RD
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):547-8. PubMed ID: 14531165
    [No Abstract]   [Full Text] [Related]  

  • 14. Removal of protein-bound substance in hepatic failure: polyetherurethane sheet embedded with powdered charcoal (UPC).
    Kawanishi H; Tsuchiya T; Nishiki M; Sugiyama M; Ezaki H
    Int J Artif Organs; 1984 Nov; 7(6):343-8. PubMed ID: 6526530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant hepatic failure and the need for artificial liver support.
    Pappas SC
    Mayo Clin Proc; 1988 Feb; 63(2):198-200. PubMed ID: 3276978
    [No Abstract]   [Full Text] [Related]  

  • 16. A 1978 perspective of hemoperfusion.
    Chang TM
    Artif Organs; 1978 Nov; 2(4):359-62. PubMed ID: 743005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of fulminant hepatic failure.
    Detry O; Honoré P; Meurisse M; Jacquet N
    Acta Chir Belg; 1998 Dec; 98(6):235-40. PubMed ID: 9922809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of fulminant hepatic failure with infusions of Co-factors and mannitol and charcoal-hemoperfusions during Forty-one days.
    Thölen H; Bianchi L; Ulrich J; Heierli C; Ritz R
    Klin Wochenschr; 1979 Sep; 57(18):949-56. PubMed ID: 502361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hemoperfusion using polyetherurethane sheet embedded with powdered charcoal (UPC) on middle molecules of hepatic failure dogs.
    Kawanishi H; Nishiki M; Kanao M; Nakagawa K; Sugiyama M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1984 Dec; 33(4):633-8. PubMed ID: 6534919
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure.
    Gimson AE; Langley PG; Hughes RD; Canalese J; Mellon PJ; Williams R; Woods HF; Weston MJ
    Lancet; 1980 Jan; 1(8161):173-5. PubMed ID: 6101632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.